L A B O R ATO RY E Q U I P M E N T M A N U FA C T U R E R P C R W E L L P L A T E S • Very high level of TiO2 to prevent “cross-talk” between the wells during the qPCR fluorescence testing procedure • Minimized background phosphorescence caused by agglomeration of TiO2 and/or oxidized (stressed) polystyrene • Preservation of polystyrene grade properties • Change control of formulation and manufacturing process • Robust product quality from batch to batch • Developed optimally dispersed, ready-to-use white formulation that maintains adequate signal transmission, as well as minimizing “cross-talk” and background phosphorescence • Optimized the use of general purpose polystyrene (GPPS) for a good balance between melt flow and other physical properties, such as stiffness • Provided comprehensive change control of raw materials and formulation, with a robust manufacturing process and quality control under a third party ISO 13485:2016 certified QMS Mevopur Healthcare Colorants and Formulations – pre-colored solution WHY AVIENT?

Wydruk informacji pobranej w trybie art. 4 ust. 4aa ustawy z dnia 20 sierpnia 1997 r. o Krajowym Rejestrze Sądowym, posiada moc dokumentu wydawanego przez Centralną Informację, nie wymaga podpisu i pieczęci. SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ) ODDZIAŁ W POLSCE 4.Nazwa lub firma przedsiębiorcy zagranicznego oraz oznaczenie formy prawnej AVIENT S.A.R.L. Podrubryka 1 Dane osób wchodzących w skład organu 1 1.Nazwisko / Nazwa lub firma KRONIMUS 2.Imiona HOLGER HANS 3.Funkcja w organie reprezentującym ZARZĄDZAJĄCY 2 1.Nazwisko / Nazwa lub firma PALM 2.Imiona CHRISTOPH 3.Funkcja w organie reprezentującym ZARZĄDZAJACY 3 1.Nazwisko / Nazwa lub firma POTOCZNY 2.Imiona ŻANETA GABRIELA 3.Funkcja w organie reprezentującym ZARZĄDZAJACY 4 1.Nazwisko / Nazwa lub firma MERKLEIN 2.Imiona NORBERT 3.Funkcja w organie reprezentującym ZARZĄDZAJĄCY Rubryka 2 ­ Organ nadzoru Brak wpisów Rubryka 3 ­ Prokurenci Brak wpisów Rubryka 4 ­ Osoby reprezentujące zagranicznego przedsiębiorcę w oddziale 1 1.Nazwisko DROJMA 2.Imiona KAMIL RAFAŁ Strona 2 z 5 3.Numer PESEL 85072613192 4.Funkcja w oddziale ­­­­­­ Dział 3 Rubryka 1 ­ Przedmiot działalności 1.Przedmiot przeważającej działalności przedsiębiorcy 1 20, 12, Z, PRODUKCJA BARWNIKÓW I PIGMENTÓW 2.Przedmiot pozostałej działalności przedsiębiorcy 1 20, 16, Z, PRODUKCJA TWORZYW SZTUCZNYCH W FORMACH PODSTAWOWYCH 2 22, 2, , PRODUKCJA WYROBÓW Z TWORZYW SZTUCZNYCH 3 22, 22, Z, PRODUKCJA OPAKOWAŃ Z TWORZYW SZTUCZNYCH 4 22, 23, Z, PRODUKCJA WYROBÓW DLA BUDOWNICTWA Z TWORZYW SZTUCZNYCH 5 22, 29, Z, PRODUKCJA POZOSTAŁYCH WYROBÓW Z TWORZYW SZTUCZNYCH 6 22, 21, Z, PRODUKCJA PŁYT, ARKUSZY, RUR I KSZTAŁTOWNIKÓW Z TWORZYW SZTUCZNYCH 7 70, 22, , POZOSTAŁE DORADZTWO W ZAKRESIE PROWADZENIA DZIAŁALNOŚCI GOSPODARCZEJ I ZARZĄDZANIA 8 68, 10, Z, KUPNO I SPRZEDAŻ NIERUCHOMOŚCI NA WŁASNY RACHUNEK 9 68, 20, Z, WYNAJEM I ZARZĄDZANIE NIERUCHOMOŚCIAMI WŁASNYMI LUB DZIERŻAWIONYMI Rubryka 2 ­ Wzmianki o złożonych dokumentach Rodzaj dokumentu Nr kolejny w polu Data złożenia Za okres od do 1.Wzmianka o złożeniu rocznego sprawozdania finansowego 1 20.02.2020 OD 11.09.2018 DO 31.12.2018 2 21.07.2021 OD 01.01.2019 DO 31.12.2019 3 10.09.2021 OD 01.01.2020 DO 31.12.2020 2.Wzmianka o złożeniu opinii biegłego rewidenta / sprawozdania z badania rocznego sprawozdania finansowego 1 ***** OD 01.01.2019 DO 31.12.2019 2 ***** OD 01.01.2020 DO 31.12.2020 3.Wzmianka o złożeniu uchwały lub postanowienia o zatwierdzeniu rocznego sprawozdania finansowego 1 ***** OD 01.01.2019 DO 31.12.2019 2 ***** OD 11.09.2018 DO 31.12.2018 Rubryka 3 Brak wpisów Rubryka 4 ­ Przedmiot działalności statutowej organizacji pożytku publicznego Brak wpisów Rubryka 5 ­ Informacja o dniu kończącym rok obrotowy 1.Dzień kończący pierwszy rok obrotowy, za który należy złożyć sprawozdanie finansowe 31.12.2018 Strona 3 z 5 Dział 4 Rubryka 1 ­ Zaległości Brak wpisów Rubryka 2 ­ Wierzytelności Brak wpisów Rubryka 3 ­ Informacje o oddaleniu wniosku o ogłoszenie upadłości na podstawie art. 13 ustawy z 28 lutego 2003 r.

2363-55D, 30% BASO4, 298C SEM Conc 2363-75D, 25% BaSO4, 298C SEM CONC 5533 MED, 25% BaSO4, 298C SEM Conc

VERSAFLEX(TM) D2109 W NEUSoft 596-50, 14% BaSO4, 2705C X GT 179430#SR-21193-4 White

NEUSOFT UR862A, 40% BaSo4 Violet C NEUSoft UR842A,20% BaS04, HLS NEUSoft UR862A,20% BaS04, HLS

Wydruk informacji pobranej w trybie art. 4 ust. 4aa ustawy z dnia 20 sierpnia 1997 r. o Krajowym Rejestrze Sądowym, posiada moc dokumentu wydawanego przez Centralną Informację, nie wymaga podpisu i pieczęci. A NR 989/2002 - ZMIENIONO §§ 4; 7 UST. 1, 2, 5; 9 UST. 2, 3, 4; 11 UST. 2, 5; 11A UST. 4; 12 UST. 2; 13 UST. 2; 17 UST. 2 UMOWY SPÓŁKI; 2 20.01.2010 R , REP. Dział 3 Rubryka 1 ­ Przedmiot działalności 1.Przedmiot przeważającej działalności przedsiębiorcy 1 20, 12, Z, PRODUKCJA BARWNIKÓW I PIGMENTÓW 2.Przedmiot pozostałej działalności przedsiębiorcy 1 46, 12, Z, DZIAŁALNOŚĆ AGENTÓW ZAJMUJĄCYCH SIĘ SPRZEDAŻĄ PALIW, RUD, METALI I CHEMIKALIÓW PRZEMYSŁOWYCH 2 20, 16, Z, PRODUKCJA TWORZYW SZTUCZNYCH W FORMACH PODSTAWOWYCH 3 46, 75, Z, SPRZEDAŻ HURTOWA WYROBÓW CHEMICZNYCH 4 69, 20, Z, DZIAŁALNOŚĆ RACHUNKOWO-KSIĘGOWA; DORADZTWO PODATKOWE 5 23, 69, Z, PRODUKCJA POZOSTAŁYCH WYROBÓW Z BETONU, GIPSU I CEMENTU 6 63, 11, Z, PRZETWARZANIE DANYCH; ZARZĄDZANIE STRONAMI INTERNETOWYMI (HOSTING) I PODOBNA DZIAŁALNOŚĆ 7 68, 20, Z, WYNAJEM I ZARZĄDZANIE NIERUCHOMOŚCIAMI WŁASNYMI LUB DZIERŻAWIONYMI Rubryka 2 ­ Wzmianki o złożonych dokumentach Rodzaj dokumentu Nr kolejny w polu Data złożenia Za okres od do 1.Wzmianka o złożeniu rocznego sprawozdania finansowego 1 07.06.2002 2001 2 02.07.2003 01.01.2002 - 31.12.2002 3 30.09.2004 OD 01.01.2003 DO 31.12.2003 4 28.06.2005 OD 01.01.2004 DO 31.12.2004 5 19.07.2006 01.01.2005-31.12.2005 6 18.06.2007 01.01.2006 R. - 31.12.2006 R. 7 27.06.2008 01.01.2007 R. - 31.12.2007 R. 8 02.07.2009 01.01.2008 R. - 31.12.2008 R. 9 30.07.2010 01.01.2009 - 31.12.2009 10 06.07.2011 2010 ROK 11 23.08.2012 01.01.2011-31.12.2011 12 25.07.2013 01.01.2012R.-31.12.2012R.

Form W-9 (Rev. October 2018) Form W-9 (Rev. No. 10231X Form W-9 (Rev. 10-2018) AVIENT CORPORATION ✔ 5 D 33587 WALKER ROAD AVON LAKE, OH 44012 3 4 1 7 3 0 4 8 8 7/20/2020

PC-3555D, 30% BaSO4 PC-3555D, 40% BaSO4 S1054A-4-1

IR Deck - AVNT-2024.06.30 (Earnings) AVIENT CORPORATION S E C O N D Q U A R T E R 2 0 2 4 R E S U L T S A N D 2 0 2 4 F I N A N C I A L G U I D A N C E (NYSE: AVNT) A U G U S T 6 , 2 0 2 4 D I S C L A I M E R Forward-Looking Statements Certain statements contained in or incorporated by reference into this presentation constitute “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. EBITDA Margin 16.9% +100 bps Q 2 2 0 2 4 R E S U L T S Q2 2024 PERFORMANCE VS. FX +4.6% FX -1.5% Total Avient +3.1% Note: Regional Sales Percentages exclude impact of foreign exchange Q2 2024 SEGMENT PERFORMANCE ( C O L O R , A D D I T I V E S & I N K S ) $525 $542 Q2 23 Q2 24 $94 $108 Q2 23 Q2 24 19.9% Sales Adjusted EBITDA (in millions) (in millions) Sales Adjusted EBITDA 7 17.9% +200 bps * * * Adjusted EBITDA Margin % • Organic sales growth in all regions led by Americas • Raw material deflation combined with cost reduction actions drove EBITDA margin expansion + 3% (+5% excluding FX) + 15% (+17% excluding FX) Q2 2024 SEGMENT PERFORMANCE ( S P E C I A LT Y E N G I N E E R E D M AT E R I A L S ) $301 $308 Q2 23 Q2 24 $60 $64 Q2 23 Q2 24 20.6% Sales Adjusted EBITDA (in millions) (in millions) Sales Adjusted EBITDA 8 19.8% +80 bps * * * Adjusted EBITDA Margin % • Sales growth in consumer, healthcare and building & construction end markets offset by weaker demand in telecommunications • EBITDA margin expansion driven by positive end market mix as well as raw material deflation + 2% (+4% excluding FX) + 7% (+8% excluding FX) 2 0 2 4 G U I D A N C E FY 20 24 GUIDA NC E Previous (May 7) Current Adjusted EBITDA $510 to $535 million $515 to $540 million Adjusted EPS $2.50 to $2.65 $2.55 to $2.70 Interest Expense $105 million $105 million Adjusted Effective Tax Rate 23% to 25% 23% to 25% Capital Expenditures ~$140 million ~$140 million 10 Q3 2024: Adjusted EPS of $0.62 11 Highlights • Provides performance updates on 2030 Sustainability Goals • Reduced company’s Scope 1 & 2 GHG emissions by 48% since 2019 • Highlights ESG performance ratings, certifications, and awards, including recent upgrades by Ecovadis to Gold and CDP to A- • Reflects Great Place to Work® culture focused on health, safety and employee engagement 20 23 SUSTAI NA BILI TY REPORT 11 Sustainability for a Better Tomorrow 2023 SUSTAINABILITY REPORT 12 • Investor Day to be held December 4, 2024 in New York, NY • The focus will be to do a deep dive on the Company’s strategy • Further details to be communicated 20 24 AVI ENT INVESTOR DAY A P P E N D I X 15 Performance Additives 15% Pigments 13% TiO2 9% Dyestuffs 2% Polyethylene 10%Nylon 5% Polypropylene 4% Styrenic Block Copolymer 4% Other Raw Materials 38% ~40% hydrocarbon based (Grey shaded materials are hydrocarbon based, includes portion of “Other Raw Materials”) Non-hydrocarbon based materials RA W MATERI AL BA SKET SEGMENT DATA U.S. & Canada 41% EMEA 36% Asia 18% Latin America 5% 2023 SEGMENT, END MARKET AND GEOGRAPHY GEOGRAPHY REVENUESEGMENT FINANCIALS Consumer 19% Packaging 23%Industrial 16% Building and Construction 9% Telecommunications 4% Energy 5% Defense 7% END MARKET REVENUE $2,007M $358M $1,138M $224M Sales EBITDA Specialty Engineered Materials Color Additives and Inks $502M$3,143M (1) Transportation 10% Healthcare 7% 17 (1) Total company sales and adjusted EBITDA of $3,143M and $502M, respectively, include intercompany sales eliminations and corporate costs 2 0 2 3 R E V E N U E | $ 2 . 0 B I L L I O N US & Canada 34% EMEA 37% Asia 21% Latin America 8% END MARKET REGION 18 Packaging 34% Consumer 21% Healthcare 8% Industrial 15% Transportation 9% Building & Construction 10% Telecommunications 1% Energy 2% COLOR , AD DI TI VES & INKS 2 0 2 3 R E V E N U E | $ 1 . 1 B I L L I O N US & Canada 52% EMEA 35% Asia 13% 19 Packaging 5% Consumer 16% Healthcare 6%Industrial 16% Transportation 12% Telecommunications 9% Energy 10% Defense 18% Building & Construction 8% END MARKET REGION SPEC IA LTY ENGI NEER ED MATERI ALS Packaging 32% Consumer 26% Healthcare 9% Industrial 13% Building & Construction 6% Telecommunications 2% Energy 2% Defense 1% Asia (18% of sales) Transportation 9% 2 0 2 3 AV I E N T R E G I O N A L S A L E S Packaging 25% Consumer 13% Healthcare 5% Industrial 18% Building & Construction 9% Energy 5% Defense 8% EMEA (36% of sales)Transportation 13% Packaging 13% Consumer 22% Healthcare 10% Industrial 16% Building & Construction 12% Energy 6% Defense 8% US & Canada (41% of sales) Transportation 9% Packaging 59% Consumer 22% Healthcare 2% Industrial 8% Building & Construction 4% LATAM (5% of sales) Transportation 5% Telecommunications 4% Telecommunications 4% 20 B Y E N D M A R K E T Reconciliation of Non-GAAP Financial Measures (Unaudited) (Dollars in millions, except for per share data) Senior management uses comparisons of adjusted net income from continuing operations attributable to Avient shareholders and diluted adjusted earnings per share (EPS) from continuing operations attributable to Avient shareholders, excluding special items, to assess performance and facilitate comparability of results.

GUIDANCE ( T O TA L C O M PA N Y ) 7 14.8% 15.8% Guidance Actual Adjusted EBITDA Margin % Better-than-expected margins driven by: • Resilient demand for composites and sustainable solutions which improved mix of higher margin applications • Deceleration of raw material inflation • Cost reduction activities Q1 EBITDA BRIDGE ( T O TA L C O M PA N Y ) 8 $ millions CAI: Price / Mix 19) Inflation (4) SEM: Price / Mix 6) Inflation (4) Net Price Benefit 17) Wage and Energy Inflation (13) Cost Reductions 8) FX (6) Q1 2023 Actual $134) Adjusted EBITDA Q1 2022 Pro Forma $ 176) Demand (48) • Weak demand conditions in-line with previous expectations • Pricing continues to cover inflation of raw materials, wages and energy U.S. & Canada 40% EMEA 38% Asia 17% Latin America 5% Q1 2023 SEGMENT, END MARKET AND GEOGRAPHY GEOGRAPHY REVENUESEGMENT FINANCIALS Consumer 18% Packaging 23% Healthcare 7% Industrial 16% Building and Construction 10% Defense 6%Telecommunications 4% Energy 5% END MARKET REVENUE (1) Total company sales and adjusted EBITDA of $846M and $134M, respectively, include intercompany sales eliminations and corporate costs $537M $91M $310M $64M Sales EBITDA Specialty Engineered Materials Color Additives and Inks $134M$846M (1) 9 Transportation 11% Q1 2 023 SA LES BY R EGI ON Y o Y C H A N G E ( E X C L . vehicles to be 100% electric by 2032 Where Avient Wins:  Lightweight panels that establish both strength and stiffness resulting in decreased energy usage, lower emissions  Long-lasting Color applications to resist UV exposure, temperature fluctuations and exceed the stylistic requirements of global automakers 14 $130 $530 Q2 FY $0.60 $2.40 Q2 FY 2023 GUIDANCE 15 Sales Adjusted EBITDA $845 $3,400 Q2 FY Adjusted EPS (in millions) (in millions) CA SH FLOW / LEV ER AGE 16 • Maintaining free cash flow and leverage guidance from February earnings call • IT investment to further integrate acquired businesses and capture operational efficiencies • Restructuring actions to streamline operations and improve profitability, primarily in Europe ($ millions) 2023E Cash Flow from Operating Activities 350$ Less: Run-Rate CapEx (110) CapEx for IT System Upgrade (25) CapEx for Restructuring (15) Total CapEx (150) Free Cash Flow 200$ Adjusted EBITDA 530$ Net Debt / Adjusted EBITDA 2.9x LONG-TERM REVENUE GROWTH DRI VERS Growth Drivers Long-Term Growth Rate Sustainable Solutions 8–12% Healthcare 8–10% Composites 10% Asia / LATAM 5% Other (GDP growth) 2–3% Avient 6.5% 17 Sustainable Solutions 32% Asia / LATAM 15% Composites 8% Healthcare 6% Other (GDP Growth) 39% • Virtual presentation to be held September 20, 2023 • The company will be conducting an investor-focused presentation around our sustainability solutions portfolio Avient Confidential 18 SUSTAINABILITY INVESTOR DAY 18 $340M $405M $455M $550M $790M $915M 2016 2017 2018 2019 2020PF** 2021 2022PF*** SUSTA INAB ILITY F OR A BETTER TOMOR ROW Revenue From Sustainable Solutions* 2016-2022 ($ in millions) Organic Future Growth Revenue Assumptions From Sustainable Solutions: 8 - 12% 19 *Avient Sustainable Solutions definitions aligned with FTC 2012 Guide for the Use of Environmental Marketing Claims (“Green Guides”) **2020 is Pro Forma to include full year of the Clariant Color business ***2022 is Pro Forma for the acquisition of Avient Protective Materials and the divestiture of Distribution $1,175M Lightweighting Eco-Conscious Recycle Solutions VOC Reduction Sustainable Infrastructure Human Health & Safety Reduced Energy Use Bio-polymers SUSTA INAB ILITY NEEDS BY M ARKET B&C • Eco-Conscious • Carbon footprint • Resource conservation Healthcare • Carbon footprint • Bio based content • Eco-Conscious Automotive • Light weighting • Recycled Content • VOC reduction Consumer • Recycle Solutions • Light weighting • Carbon Footprint Packaging • Recycle Solutions • Light weighting • Food waste reduction Common Theme: CO2 Emission Goals Increasing Single-Use Plastic Regulation 20 I NV ESTI NG I N INNOVATI ON S U S T A I N A B I L I T Y P O R T F O L I O 21 A P P E N D I X 24 RAW MATERIAL 2022 ANNUAL PURCHASES Performance Additives 16% Pigments 12% TiO2 10% Dyestuffs 2% Polyethylene 11% Nylon 6% Polypropylene 5% Styrenic Block Copolymer 5% Other Raw Materials 33% ~40% hydrocarbon based (Grey shaded materials are hydrocarbon based, includes portion of “Other Raw Materials”) Non-hydrocarbon based materials • Cost inflation decelerating, particularly for hydrocarbon-based raw materials 2022 pro forma results for the acquisition of Avient Protective Materials SEGMENT DATA U.S. & Canada 40% EMEA 37% Asia 18% Latin America 5% 2022 PRO FORMA SEGMENT, END MARKET AND GEOGRAPHY GEOGRAPHY REVENUESEGMENT FINANCIALS Consumer 20% Packaging 24% Industrial 15% Building and Construction 10% Telecommunications 4% Energy 4% Defense 6% END MARKET REVENUE $2,355M $402M $1,300M $272M Sales EBITDA Specialty Engineered Materials Color Additives and Inks $592M$3,653M (1) Transportation 9% Healthcare 8% 26 (1) Total company sales and adjusted EBITDA of $3,653M and $592M, respectively, include intercompany sales eliminations and corporate costs C O L O R , A D D I T I V E S & I N K S 2 0 2 2 R E V E N U E | $ 2 . 4 B I L L I O N US & Canada 34% EMEA 38% Asia 20% Latin America 8% END MARKET REGION 27 Packaging 34% Consumer 21% Healthcare 8% Industrial 15% Transportation 8% Building & Construction 11% Telecommunications 1% Energy 2% S P E C I A L T Y E N G I N E E R E D M A T E R I A L S 2 0 2 2 P R O F O R M A R E V E N U E | $ 1 . 3 B I L L I O N END MARKET US & Canada 52% EMEA 35% Asia 13% REGION 28 Packaging 5% Consumer 19% Healthcare 8%Industrial 16% Transportation 10% Telecommunications 10% Energy 9% Defense 15% Building & Construction 8% Packaging 32% Consumer 27% Healthcare 8% Industrial 14% Building & Construction 5% Telecommunications 3% Energy 1% Defense 1% Asia (18% of sales) Transportation 9% 2 0 2 2 P R O F O R M A AV I E N T R E G I O N A L S A L E S B Y E N D M A R K E T Packaging 27% Consumer 14% Healthcare 5% Industrial 17% Building & Construction 10% Energy 5% Defense 8% EMEA (37% of sales)Transportation 11% Packaging 13% Consumer 24% Healthcare 12% Industrial 15% Building & Construction 13% Energy 5% Defense 5% US & Canada (40% of sales) Transportation 7% Packaging 56% Consumer 23% Healthcare 4% Industrial 7% Building & Construction 4% Telecommunications 1% LATAM (5% of sales) Transportation 5% Telecommunications 3% Telecommunications 6% 29 PEER COMPARISONS AV I E N T I S A S SE T L I G H T Capex / Revenue 2023E (%) Avient Specialty Formulators Other Specialty / Chemical Companies Source: Peer data per Bloomberg as of April 28, 2023 Note: Avient reflects 2023 estimated revenue of $3,400 and estimated run-rate CAPEX of $110M. 31 3 2 3 3 4 4 3 3 5 5 5 6 7 9 A vi e n t K W R P P G F U L R P M A V Y F M C H U N H X L C E E C L A S H E M N S C L F R E E C A S H F LOW C O N V E R S I O N Source: Peer data per Bloomberg as of April 28, 2023 Note: Free cash flow conversion calculated as (Adjusted EBITDA – Capex) / Adjusted EBITDA. Avient Specialty Formulators Other Specialty / Chemical Companies 2023E(%) 32 79 87 83 81 76 73 90 79 77 76 73 69 60 22 A vi e n t K W R P P G F U L A V Y R P M F M C C E H X L A S H E C L H U N E M N S C L M U LT I P L E E X PA N S I O N Avient Specialty Formulators Other Specialty / Chemical Companies Source: Peer data per Bloomberg as of April 28, 2023 Note: Avient reflects 2023 adjusted EBITDA guidance of $530M and closing share price of $38.51.